Healthy Life, Breakthrough Medicines
Harbour BioMed (harbourbiomed.com) scores 60 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, in the 6th percentile of 12576 Healthcare brands.
Harbour BioMed (HBM Holdings) is a global biopharmaceutical company headquartered in Rotterdam, Netherlands, founded in 2016. It focuses on the research, development, and commercialization of novel antibody therapeutics for oncology and immunological diseases. The company uses proprietary technologies such as Harbour Mice®, HBICE®, and HCAb PLUS™, combined with AI, to build an antibody discovery engine. It operates through internal R&D, global collaborations, and strategic acquisitions, targeting pharmaceutical and biotech partners, investors, and patients.
| Brand Name | Harbour BioMed |
|---|---|
| Domain | harbourbiomed.com |
| Industry | Healthcare |
| Founded | 2016 |
| Headquarters | Rotterdam |
| Main Competitors | Regeneron Pharmaceuticals (92/100), Genmab (83/100), argenx (83/100), Ligand Pharmaceuticals (OmniAb) (82/100), Trianni (74/100), Kymab, MorphoSys (82/100), Adimab (76/100) |
Moz Domain Authority 34/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #1,815,331 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Harbour BioMed (HBM Holdings) is a global biopharmaceutical company committed to the r&d and commercialization of novel antibody therapeutics in oncology and immunological dise…" (Meta description: 24 words (ideal length). No OG description (falling back to meta)) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Nginx.
Social footprint: verified profiles on LinkedIn, Facebook, Instagram; no detected presence on X (Twitter), YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Harbour BioMed?", Claude could identify the brand as of September 2026. Harbour BioMed is a global biopharmaceutical company focused on discovering and developing fully human antibody therapeutics, best known for its proprietary Harbour Mice transgenic mouse platforms used to generate conventional and heavy-chain-only antibodies. It has partnered wit Best known for its Harbour Mice transgenic antibody discovery platform for generating fully human antibodies.
When asked "Best brands similar to Harbour BioMed?", Claude would recommend Harbour BioMed as of September 2026. It's a notable player in antibody discovery technology and biologics licensing, so it would come up in discussions of innovative Chinese/global biotech antibody platforms.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Harbour BioMed's main competitors in Healthcare: Regeneron Pharmaceuticals (92/100), Genmab (83/100), argenx (83/100), Ligand Pharmaceuticals (OmniAb) (82/100), Trianni (74/100).
Sources: Brand Analyzer scan
Harbour BioMed is a global biopharmaceutical company headquartered in Rotterdam, Netherlands, founded in 2016. It is dedicated to the research, development, and commercialization of novel antibody therapeutics, primarily for oncology and immunological diseases.
Sources: Harbour BioMed official site
Harbour BioMed has low AI-search visibility, scoring 23/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 19, recommendation 30). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Harbour BioMed official site
Harbour BioMed was founded in 2016. Harbour BioMed operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Harbour BioMed is headquartered in Rotterdam. Harbour BioMed operates in the Healthcare category.
Sources: Wikidata
Harbour BioMed discovers and develops antibody-based therapeutics for oncology and immunological diseases. It uses proprietary discovery platforms-Harbour Mice®, HBICE®, and HCAb PLUS™-combined with AI to identify and engineer novel antibodies. The company advances these candidates through internal R&D programs, global partnerships with pharmaceutical and biotech companies, and strategic acquisitions, aiming to bring new antibody treatments to patients.
Sources: Harbour BioMed official site
Harbour BioMed scores 30/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Harbour BioMed official site
Harbour BioMed offers antibody discovery and development services and technologies, centered on its proprietary Harbour Mice®, HBICE®, and HCAb PLUS™ platforms. These are used to develop novel antibody therapeutics for oncology and immunological diseases. The company also engages in R&D collaborations, licensing, and partnership arrangements with pharmaceutical and biotech companies to advance these therapeutic candidates.
Sources: Harbour BioMed official site
Harbour BioMed can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Harbour BioMed official site
Harbour BioMed is known for its proprietary antibody discovery technologies, including Harbour Mice®, a transgenic mouse platform for generating fully human antibodies, as well as HBICE® and HCAb PLUS™ platforms. These technologies, combined with AI-driven approaches, form the basis of its differentiated antibody discovery engine used in oncology and immunology research.
Sources: Harbour BioMed official site
Harbour BioMed's offerings are used by pharmaceutical and biotech companies seeking partnerships for antibody drug discovery and development, as well as investors interested in its therapeutic pipeline and technology platforms. Ultimately, patients with oncology and immunological diseases are the intended beneficiaries of the antibody therapeutics developed through the company's platforms and collaborations.
Sources: Harbour BioMed official site
Harbour BioMed scores 23/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Harbour BioMed has a weak AI-visibility profile at 23/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (30/100) and its weakest is trust (19/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #1,815,331 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 34/100 and thin schema.org structured data. In a live check, Claude could already identify Harbour BioMed from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Harbour BioMed: Great Ideas for Teaching (60/100), Gandhi Eye Centre (60/100), Healing Touch Program (60/100), HealthTrust Workforce (60/100).
A step up - brands to learn from: ZT Corporate (71/100), Zorgnet-Icuro (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.